Supg could realize .55 EPS in the first quarter. A few things must fall in place but if Mayne buyout goes through and Nipent Eu gets done....were looking at about 39M in revenues in the first quarter. This would put cash at 100M by 3/31/07. Dacogen should get a nice increase with the J code. Watch for a run at 6.00 late December as Mayne deal gets near completition and updates on Dacogen AML and Dacogen EU MDS get released. The AML news should be released at ASH conference.
2007 looks like it will shape up for growth with news coming from several directions...pipeline, partnerships,spinouts on pipeline,milestones, dacogen growth, trial updates. However this stock looks like a steady long term growth company. If your short your screwed...no real bad news on the horizon and if your a trader...no real large breakouts. Just slow appreciation throughtout 2007.